Mice lacking Angiotensinogen or Ang II receptor genes show decreased obesity, insulin resistance, and hypertension (Massiera et al., 2001; Yvan-Charvet et al., 2005), supporting the notion that RAAS activation contributes to COVID-19 comorbidities. This evidence concerns the gene AGT and hypertensive disorder.